Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | PPP1R16B |
| Upstream (Parents) |
|---|
| (<<) P2RY8 → PPP1R16B |
| (<<) PRKCB → PPP1R16B |
| (<<) CXCR3 → PPP1R16B |
| Downstream (Children) |
|---|
| PPP1R16B → FGD3 (>>) |
| PPP1R16B → RAB39B (>>) |
| PPP1R16B → P2RY8 (>>) |
| PPP1R16B → TOX2 (>>) |
| PPP1R16B → CYFIP2 (>>) |
| PPP1R16B → PAG1 (>>) |
| PPP1R16B → N4BP2L1 (>>) |
| PPP1R16B → MAP4K1 (>>) |
| PPP1R16B → FCRL3 (>>) |
| PPP1R16B → PLOD2 (>>) |
| PPP1R16B → PRKCB (>>) |
| PPP1R16B → TRAF3IP3 (>>) |
| PPP1R16B → CDC42SE2 (>>) |
| PPP1R16B → PRKCQ (>>) |
| PPP1R16B → MAL (>>) |
| PPP1R16B → PASK (>>) |
| PPP1R16B → BMP6 (>>) |
| PPP1R16B → CREBL2 (>>) |
| PPP1R16B → STAMBPL1 (>>) |
| PPP1R16B → CXCR3 (>>) |
